V-Wave

About

Funding history · 4 rounds · $132.5M total

Headcount over time

Q&A

When was V-Wave acquired and by whom?

V-Wave was acquired by Johnson & Johnson in October 2024 for an amount of $1.7 billion.

What is V-Wave's primary product?

V-Wave's primary product is the V-Wave Ventura Interatrial Shunt, an investigational device designed to reduce elevated left atrial pressure in patients with severe symptomatic heart failure.

What was the outcome of the FDA committee review for V-Wave's product in December 2025?

In December 2025, an FDA committee voted against approving V-Wave's product, which threatened the contingent value of its acquisition.

When did V-Wave complete enrollment for its RELIEVE-HF trial?

V-Wave completed enrollment in the RELIEVE-HF randomized double-blind controlled trial of interatrial shunting for heart failure in October 2022.

Which investors participated in V-Wave's $98 million financing round in December 2021?

V-Wave completed a $98 million financing round in December 2021, with Deerfield Management as a lead investor.

When did V-Wave receive CE Mark for its Ventura Interatrial Shunt System?

V-Wave secured CE Mark for its Ventura Interatrial Shunt System in March 2020.

What was the total amount of funding V-Wave raised before its acquisition?

V-Wave raised a total of $132.5 million before its acquisition.

Team · 3

Dr. Ascher Shmulewitz

Founder · Founder

Prof. Gad Keren

Founder · Founder

Yaakov Nitzan

Founder · Founder

Sectors & technology

Highlights

Tags